--- title: "IBA discloses information on its share buyback program announced on Feb 2, 2026 as per Belgian regulations." type: "News" locale: "zh-CN" url: "https://longbridge.com/zh-CN/news/276071305.md" description: "Louvain-la-Neuve, Belgium, February 16, 2026, at 6 PM CET: Ion Beam Applications SA (\"IBA\") is complying with article 8:4 of the Royal Decree dated April 29, 2019, which implements the Belgian Code on Companies and Associations. This disclosure pertains to IBA's share buyback initiative launched on February 2, 2026." datetime: "2026-02-16T17:02:25.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/276071305.md) - [en](https://longbridge.com/en/news/276071305.md) - [zh-HK](https://longbridge.com/zh-HK/news/276071305.md) --- > 支持的语言: [English](https://longbridge.com/en/news/276071305.md) | [繁體中文](https://longbridge.com/zh-HK/news/276071305.md) # IBA discloses information on its share buyback program announced on Feb 2, 2026 as per Belgian regulations. Louvain-la-Neuve, Belgium, February 16, 2026, at 6 PM CET: Ion Beam Applications SA ("IBA") is complying with article 8:4 of the Royal Decree dated April 29, 2019, which implements the Belgian Code on Companies and Associations. This disclosure pertains to IBA's share buyback initiative launched on February 2, 2026. ### 相关股票 - [Invesco Nasdaq Biotechnology ETF (IBBQ.US)](https://longbridge.com/zh-CN/quote/IBBQ.US.md) - [ALPS Medical Breakthrough (SBIO.US)](https://longbridge.com/zh-CN/quote/SBIO.US.md) - [Proshares Ultra Nasdaq Biotech (BIB.US)](https://longbridge.com/zh-CN/quote/BIB.US.md) - [Invesco Biotechnology & Genome ETF (PBE.US)](https://longbridge.com/zh-CN/quote/PBE.US.md) - [Beam Therapeutics (BEAM.US)](https://longbridge.com/zh-CN/quote/BEAM.US.md) - [SPDR S&P Biotech (XBI.US)](https://longbridge.com/zh-CN/quote/XBI.US.md) - [First Trust NYSE Arca Biotech Index Fd (FBT.US)](https://longbridge.com/zh-CN/quote/FBT.US.md) - [iShares Biotechnology ETF (IBB.US)](https://longbridge.com/zh-CN/quote/IBB.US.md) - [VanEck Biotech ETF (BBH.US)](https://longbridge.com/zh-CN/quote/BBH.US.md) ## 相关资讯与研究 - [Beam Therapeutics Insider Sold Shares Worth $1,128,315, According to a Recent SEC Filing](https://longbridge.com/zh-CN/news/281490970.md) - [Io Biotech Inc - Files Voluntary Chapter 7 Bankruptcy Petition On March 31, 2026 - SEC Filing](https://longbridge.com/zh-CN/news/281187506.md) - [BUZZ-Caribou rises on FDA's regenerative medicine advanced therapy tag for blood cancer therapy](https://longbridge.com/zh-CN/news/281186075.md) - [Iterum Therapeutics Received Notice of Delisting](https://longbridge.com/zh-CN/news/281174211.md) - [RenovoRx Named to Fast Company’s Annual List of the World’s Most Innovative Companies of 2026 | RNXT Stock News](https://longbridge.com/zh-CN/news/281410663.md)